Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells

(2019) Mingqi Wang et al.   GENE

microRNA as a systemic intervention in the specific breast cancer subtypes with C-MYC impacts; introducing subtype-based appraisal tool

(2018) Vida Pourteimoor et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The 9p21 locus: A potential therapeutic target and prognostic marker in breast cancer

(2018) Mahdi Rivandi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Ozone affects leaf physiology and causes injury to foliage of native tree species from the tropical Atlantic Forest of southern Brazil

(2018) Bárbara Baêsso Moura et al.   SCIENCE OF THE TOTAL ENVIRONMENT

ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM

(2018) Xiang Zhang et al.   Cell Death & Disease

Interplay Between Long Noncoding RNA ZEB1-AS1 and miR-200s Regulates Osteosarcoma Cell Proliferation and Migration

(2017) Chibo Liu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression

(2017) Changyi Fang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

ZEB1-regulated inflammatory phenotype in breast cancer cells

(2017) Akihiro Katsura et al.   Molecular Oncology

High expression of long non-coding RNA ZEB1-AS1 promotes colorectal cancer cell proliferation partially by suppressing p15 expression

(2017) Huangbo Gong et al.   TUMOR BIOLOGY

ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer

(2017) Jianbo Zhang et al.   Cell Death & Disease

Long Noncoding RNAs in Atherosclerosis

(2016) Liguo Jian et al.   Journal of Atherosclerosis and Thrombosis

Supernatants of Adipocytes From Obese Versus Normal Weight Women and Breast Cancer Cells: In Vitro Impact on Angiogenesis

(2016) Lauriane Bougaret et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Breast Cancer Therapy–Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study

(2016) Paaladinesh Thavendiranathan et al.   JOURNAL OF CLINICAL ONCOLOGY

ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer

(2016) Lingjia Liu et al.   PLoS One

Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop

(2016) Xiunan Li et al.   TUMOR BIOLOGY

Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells

(2016) Yao-Min Chen et al.   TUMOR BIOLOGY

Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma

(2015) T Li et al.   ONCOGENE

Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer

(2015) Yue Yu et al.   Oncotarget

Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer

(2015) Ehsan Malek et al.   Oncotarget

Functional Roles of Long Non-coding RNA in Human Breast Cancer

(2014) Ni Ye et al.   Asian Pacific Journal of Cancer Prevention

The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma

(2013) E Sánchez-Tilló et al.   CELL DEATH AND DIFFERENTIATION

Emodin affects ERCC1 expression in breast cancer cells

(2013) Jian-min Fu et al.   Journal of Translational Medicine

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

(2013) Andrew J Souers et al.   NATURE MEDICINE

Anticancer Agent Shikonin Is an Incompetent Inducer of Cancer Drug Resistance

(2013) Hao Wu et al.   PLoS One

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1

(2012) Laisheng Li et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Overexpression of forkhead box J2 can decrease the migration of breast cancer cells

(2012) Yingying Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line

(2012) Katerina D. Fagan-Solis et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population

(2011) Hua-Jie Dong et al.   LEUKEMIA & LYMPHOMA

Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line

(2010) Huan Meng et al.   ACS Nano

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

(2010) Igor P. Pogribny et al.   INTERNATIONAL JOURNAL OF CANCER

microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling

(2010) Z. Yu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

(2009) Yanlin Sun et al.   BREAST CANCER RESEARCH AND TREATMENT

Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells

(2009) Tisheeka R. Graham et al.   BREAST CANCER RESEARCH AND TREATMENT